CN108707181A - 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 - Google Patents
一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 Download PDFInfo
- Publication number
- CN108707181A CN108707181A CN201810615496.1A CN201810615496A CN108707181A CN 108707181 A CN108707181 A CN 108707181A CN 201810615496 A CN201810615496 A CN 201810615496A CN 108707181 A CN108707181 A CN 108707181A
- Authority
- CN
- China
- Prior art keywords
- bitter gourd
- gourd polypeptide
- cell proliferation
- tumor cell
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 106
- 235000009811 Momordica charantia Nutrition 0.000 title claims abstract description 84
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 73
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 69
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 title claims abstract description 66
- 210000004881 tumor cell Anatomy 0.000 title claims abstract description 29
- 230000004663 cell proliferation Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 10
- 244000078912 Trichosanthes cucumerina Species 0.000 title 1
- 244000302512 Momordica charantia Species 0.000 claims abstract description 85
- 239000007788 liquid Substances 0.000 claims abstract description 56
- 239000006228 supernatant Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 27
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 18
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 11
- 238000007710 freezing Methods 0.000 claims abstract description 10
- 230000008014 freezing Effects 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 15
- 230000005764 inhibitory process Effects 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000010257 thawing Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 5
- 239000012498 ultrapure water Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 3
- 235000005911 diet Nutrition 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 235000014102 seafood Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 230000008901 benefit Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000011149 active material Substances 0.000 abstract description 2
- 210000002421 cell wall Anatomy 0.000 abstract description 2
- 238000004090 dissolution Methods 0.000 abstract description 2
- 238000000227 grinding Methods 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract 1
- 238000009288 screen filtration Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 84
- 238000002474 experimental method Methods 0.000 description 19
- 230000006907 apoptotic process Effects 0.000 description 17
- 238000001514 detection method Methods 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 15
- 239000000243 solution Substances 0.000 description 11
- 230000014509 gene expression Effects 0.000 description 10
- 206010017758 gastric cancer Diseases 0.000 description 9
- 208000005718 Stomach Neoplasms Diseases 0.000 description 8
- 201000011549 stomach cancer Diseases 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000006285 cell suspension Substances 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 102000001400 Tryptase Human genes 0.000 description 5
- 108060005989 Tryptase Proteins 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 102000047934 Caspase-3/7 Human genes 0.000 description 4
- 108700037887 Caspase-3/7 Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 4
- 241000796533 Arna Species 0.000 description 3
- 102000011727 Caspases Human genes 0.000 description 3
- 108010076667 Caspases Proteins 0.000 description 3
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 3
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003186 pharmaceutical solution Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Water Supply & Treatment (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
细胞名 | 培养基信息 |
AGS | F12+10%FBS |
MGC80-3 | 1640+10%FBS |
细胞名 | 培养基信息 |
AGS | F12+10%FBS |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810615496.1A CN108707181B (zh) | 2018-06-14 | 2018-06-14 | 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810615496.1A CN108707181B (zh) | 2018-06-14 | 2018-06-14 | 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108707181A true CN108707181A (zh) | 2018-10-26 |
CN108707181B CN108707181B (zh) | 2021-03-12 |
Family
ID=63872621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810615496.1A Active CN108707181B (zh) | 2018-06-14 | 2018-06-14 | 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108707181B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112047997A (zh) * | 2020-08-10 | 2020-12-08 | 苏秀兰 | 一种肉苁蓉多肽混合物、其制备方法及其应用 |
CN112442107A (zh) * | 2020-11-18 | 2021-03-05 | 渤海大学 | 一种苦味抑制肽及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2285452A1 (en) * | 1997-04-01 | 1998-10-08 | Calyx Therapeutics, Inc. | Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
CN102851344A (zh) * | 2012-08-31 | 2013-01-02 | 华南理工大学 | 一种螺旋藻抗肿瘤多肽的制备方法 |
CN107129859A (zh) * | 2017-05-09 | 2017-09-05 | 重庆第二师范学院 | 一种提高油橄榄鲜榨出油率的加工方法 |
-
2018
- 2018-06-14 CN CN201810615496.1A patent/CN108707181B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2285452A1 (en) * | 1997-04-01 | 1998-10-08 | Calyx Therapeutics, Inc. | Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
CN102851344A (zh) * | 2012-08-31 | 2013-01-02 | 华南理工大学 | 一种螺旋藻抗肿瘤多肽的制备方法 |
CN107129859A (zh) * | 2017-05-09 | 2017-09-05 | 重庆第二师范学院 | 一种提高油橄榄鲜榨出油率的加工方法 |
Non-Patent Citations (1)
Title |
---|
VERMONT P. DIA ET AL.: "BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells", 《SCIENTIFIC REPORTS》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112047997A (zh) * | 2020-08-10 | 2020-12-08 | 苏秀兰 | 一种肉苁蓉多肽混合物、其制备方法及其应用 |
CN112442107A (zh) * | 2020-11-18 | 2021-03-05 | 渤海大学 | 一种苦味抑制肽及其应用 |
CN112442107B (zh) * | 2020-11-18 | 2023-05-09 | 渤海大学 | 一种苦味抑制肽及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108707181B (zh) | 2021-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1856568B (zh) | 发酵和培养的方法、植物发酵提取物、植物发酵提取物粉末以及含有植物发酵提取物的组合物 | |
CN101433620B (zh) | 一种龙眼水溶性活性物质及其提取方法和应用 | |
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
CN101248866A (zh) | 从河蚌中同时提取蚌肉提取物、蛋白粉和多肽粉的方法 | |
CN104163847B (zh) | 蝇蛆活性蛋白肽的制备方法与所制备的蝇蛆活性蛋白肽及其用途 | |
CN108707181A (zh) | 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 | |
CN101249259A (zh) | 一种高含量、高活性口服云芝糖肽及其制备方法和应用 | |
CN104306399B (zh) | 一种鹿脾提取物提取方法及在提高免疫力药物中的应用 | |
CN108402472B (zh) | 一种女用蚕蛹提取生物蛋白 | |
CN102167726A (zh) | 一种利用动物血液和脾脏分离提取活性多肽和免疫核糖核酸的方法 | |
CN1092264A (zh) | 鲜猴头菇饮品及其工业化的生产方法 | |
CN106834404A (zh) | 一种酶解多肽及用于制备治疗肺腺癌药物的用途 | |
CN115644455B (zh) | 牛脾肽粉在改善肠道功能中的用途 | |
JP2009191009A (ja) | 免疫賦活作用および抗腫瘍作用を有するマイタケ由来の低分子物質 | |
CN100544736C (zh) | 一种增强免疫力的药物组合物及制备方法 | |
CN107836613A (zh) | 小球藻生长因子螺旋藻多糖功能饮品制备方法 | |
CN106805252A (zh) | 一种鱼短肽及其在营养强化剂中的应用 | |
CN113181235A (zh) | 板栗花粉提取物的制备方法及应用 | |
CN112079938A (zh) | 一种青稞多糖的提取方法、青稞多糖提取物及其应用 | |
CN1171630C (zh) | 从香菇菌丝体的提取物来源的lak活性增强剂和含有此提取物的lak活性增强配方 | |
CN111067108A (zh) | 一种玫瑰苦荞多肽口服液及其制备方法 | |
CN113491331B (zh) | 一种海藻多糖组合物与复合果汁混合发酵粉及其制备方法与应用 | |
CN113667608B (zh) | 一株朱红硫磺菌及其在治疗消化道溃疡和结肠炎中的应用 | |
CN117482182A (zh) | 组合物及其制备方法和应用 | |
CN113667710A (zh) | 一种抑制癌细胞增殖的鸡源蛋白水解物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 610000 Huaxi campus, No. three, 17 South Renmin Road, Sichuan, Chengdu Applicant after: Su Xiulan Address before: 010050 the 1 Affiliated Hospital of Inner Mongolia Medical University, north channel, Huimin District, Hohhot, the Inner Mongolia Autonomous Region Applicant before: Su Xiulan |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB02 | Change of applicant information |
Address after: 010050 Affiliated Hospital of Inner Mongolia Medical University, 1 Tongdao North Street, Huimin District, Hohhot, Inner Mongolia Autonomous Region Applicant after: Su Xiulan Address before: Huaxi campus of Sichuan University, No.17, section 3, Renmin South Road, Chengdu, Sichuan 610000 Applicant before: Su Xiulan |
|
CB02 | Change of applicant information |